DXCM vs ROL · P/E 63, rev $2.50B vs P/E 41, rev $1.99B
DexCom Inc (DXCM) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the DXCM and ROL stock pages for the full models.
Not investment advice.